outlook provid preliminari commentari
key take-away make progress toward
previous state goal return market growth rate
albeit modest pace compani maintain outlook
organ revenu growth get weight
averag market growth wamgr ep growth
temper next year deliv meaning leverag
beyond result adjust
estim better reflect compani growth profil
revenu versu guidanc
ep look top-
line organ revenu growth ep growth low-
singl digit maintain outperform rate
base approxim ep estim
result slightli better-than-expect revenu
y/i y/i ex-fx exceed estim
consensu quarter benefit easi
y/i comp due hurrican prior year quarter
tender time asia pacif europ middl east africa
emea time capit sale sport medicin
extrem trauma set busi fx headwind
versu estim zbh ex-fx organ sale
growth y/i compar came
ahead estim stack growth howev
deceler versu
revenu ep guidanc rang provid manag
anticip ep would around sequenti due
time bonu payout typic season zbh
print consist outlook adj ep
y/i sequenti exceed estim
consensu
continu page
compani data secur llc estim reuter
ep exclud amort non-recur item
compani data secur llc estim reuter
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
continu previou page
outlook updat fx tax look report revenu growth
slightli prior due fx less tailwind previous anticip
prior chang underli growth flat
impli revenu slightli bracket new estim
net sell day impact full year compani note tough y/i comp
impact tender capit sale time revers tailwind addit termin
us distribut agreement bone cement supplier heraeu palaco cost
quarter begin fx increment headwind well maintain adj ep
guidanc rang repres declin y/i bracket new
estim expect adj oper margin remain rang adj tax rate
slightli low-end prior rang rang
provid initi outlook provid formal guidanc provid
color top-lin currenc prevail rate bone cement us distribut
issu expect headwind sale respect
headwind ep gross margin expect pressur due capit cost benefit
product improv like occur larg driven outlook gross
margin anticip oper margin expans posit side suppli
recoveri new product launch full launch product posit zbh
salesforc get offenc addit lower interest expens aid debt repay lower
effect tax rate also help ep growth
segment result stack follow exceed expect hip spine cmf
craniomaxillofaci dental miss knee set sport extrem trauma sale
growth repres y/i ex-fx rate versu stack follow
knee sale versu compar estim
growth driven sequenti improv europ middl east
africa emea america asia pacif knee price slightli wors
sequenti versu volum nice versu
benefit continu uptak persona knee platform
off-set competit headwind us manag note call persona
partial knee procedur perform surgeon feedback strong
persona revis system well rosa total knee applic tka progress well
await regulatori approv fact rosa tka progress ahead schedul perform
first case australia look limit launch follow full
launch
hip sale versu compar estim
growth driven notabl acceler america asia
pacif off-set sequenti deceler emea hip price wors
versu volum tick nice versu
segment benefit easi prior year comp improv suppli warsaw
sport medicin extrem trauma set sale versu
compar estim set price continu improv
versu along volum versu zbh
sequenti acceler primarili driven time tender capit
sale shift volum henc sale neg
impact manag note suppli constraint continu affect busi expect
growth improv led new product launch improv special
spine craniomaxillofaci cmf sale versu
compar estim spine cmf price improv notabl
versu volum slightli lower sequenti versu
sequenti deceler due impact continu sale forc integr
dis-synergi said make good progress rosa spine await regulatori
approv devic fulli integr spine cranial applic
dental sale versu compar estim
dental price continu improv versu volum flat
versu result sequenti acceler continu make
progress portfolio realign sale reorgan select geographi
metricswfconsensusrevenu knee extrem trauma cmf cmf cmf craniomaxillofaci factset revenu compani report secur llc estim factset visibl alpha explicitli state consensu visibl alpha may vari base broker contribut medic technolog
fiscal year end decemb spine cost good gross sell gener adminstr research total oper oper incom interest expens incom incom incom tax provis net incom minor net adjust dilut share adjust ep excl gener adminstr oper incom ebitda excl gener adminstr oper incom restat effect relat revenu custom contract present net period pension postretir benefit cost sourc compani report factset secur llc estim inc
price target nc
price target base approxim cash ep estim risk thesi
includ increas invest slower procedur volum growth price pressur disrupt
integr biomet
zimmer biomet share trade discount large-cap med-tech peer group believ
discount narrow next twelv month compani benefit leadership
new commercially-driven ceo bryan hanson oper issu resolv pipelin
begin fulli appreci
warsaw indiana-bas zimmer biomet hold one world largest orthoped implant
manufactur compani global market leader billion reconstruct orthoped
implant busi hip knee implant togeth account roughli revenu
compani report sale billion
